E-LIB Suche - Ergebnisse für: Mancuso, Maria Elisa

1

Simoctocog alfa (Nuwiq®) in previously untreated patients w..:

Mathias, Mary ; Abraham, Aby ; Belletrutti, Mark...
info:eu-repo/semantics/altIdentifier/doi/10.1111/ejh.14040. , 2023

Link: https://univ-rennes.hal...

2

Efficacy of rFIXFc versus N9-GP Prophylaxis in Patients wit..:

Mancuso, Maria Elisa ; Eriksson, Daniel ; Falk, Aletta...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390690/. , 2023

Link: http://www.ncbi.nlm.nih...

3

Simoctocog alfa (Nuwiq®) in previously untreated patients w..:

Mathias, Mary ; Abraham, Aby ; Belletrutti, Mark...
info:eu-repo/semantics/altIdentifier/doi/10.1111/ejh.14040. , 2023

Link: https://univ-rennes.hal...

4

F8/F9 variants in the population-based PedNet Registry coho..:

Labarque, Veerle ; Mancuso, Maria Elisa ; Kartal-Kaess, Mutlu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926204/. , 2023

Link: http://www.ncbi.nlm.nih...

5

Efficacy of rFIXFc versus N9-GP Prophylaxis in Patients wit..:

Mancuso, Maria Elisa ; Eriksson, Daniel ; Falk, Aletta...
info:eu-repo/semantics/altIdentifier/doi/10.2147/JBM.S389094. , 2023

Link: https://www.dovepress.co..

6

Laying the foundations for gene therapy in Italy for patien..:

Castaman, Giancarlo ; Carulli, Christian ; De Cristofaro, Raimondo...
info:eu-repo/semantics/altIdentifier/pmid/36469855. , 2023

Link: https://hdl.handle.net/1..

7

Extended half-life factor IX prophylaxis up to every 21 day..:

Pabinger, Ingrid ; Lissitchkov, Toshko ; Nagao, Asuza...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394546/. , 2023

Link: http://www.ncbi.nlm.nih...

8

Efficacy and safety of damoctocog alfa pegol prophylaxis in..:

Reding, Mark T ; Pabinger, Ingrid ; Holme, Pål Andre...
Reding, Mark T. Pabinger, Ingrid Holme, Pål Andre Maas Enriquez, Monika Mancuso, Maria Elisa Lalezari, Shadan Miesbach, Wolfgang Di Minno, Giovanni Klamroth, Robert Hermans, Cedric . Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities: post hoc analysis from the PROTECT VIII study. Therapeutic Advances in Hematology (TAH). 2023, 14. , 2023

Link: http://hdl.handle.net/10..

9

Hemophilia treatment in 2021: choosing the"optimal" treatme..:

Hermans, Cedric ; Noone, Declan ; Benson, Gary...
Blood Reviews. , 2023

Link: http://hdl.handle.net/10..

10

Efficacy and safety of damoctocog alfa pegol prophylaxis in..:

Reding, Mark T ; Pabinger, Ingrid ; Holme, Pål Andrè...
boreal:275609. , 2023

Link: http://hdl.handle.net/20..

11

Simoctocog alfa (Nuwiq®) in previously untreated patients w..:

Mathias, Mary ; Abraham, Aby ; Belletrutti, Mark...
info:eu-repo/semantics/altIdentifier/doi/10.1111/ejh.14040. , 2023

Link: https://univ-rennes.hal...

12

Research and Practice in Thrombosis and Haemostasis / Exten..:

Pabinger, Ingrid ; Lissitchkov, Toshko ; Nagao, Asuza...
vignette : https://repositorium.meduniwien.ac.at/titlepage/urn/urn:nbn:at:at-ubmuw:3-79630/128. , 2023

Link: https://doi.org/10.1016/..

13

Efficacy and safety of damoctocog alfa pegol prophylaxis in..:

Reding, Mark T ; Pabinger, Ingrid ; Holme, Pål Andrè...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126693/. , 2023

Link: http://www.ncbi.nlm.nih...

14

Efficacy and safety of damoctocog alfa pegol prophylaxis in..:

Reding, Mark T ; Pabinger, Ingrid ; Holme, Pål Andrè...
boreal:275609. , 2023

Link: http://hdl.handle.net/20..

15

F8/F9 variants in the population-based PedNet Registry coho..:

Labarque, Veerle ; Mancuso, Maria Elisa ; Kartal-Kaess, Mutlu...
https://pure.au.dk/portal/en/publications/a6d985c6-c686-4135-b6b8-a099d8a15ff4. , 2023

Link: https://pure.au.dk/porta..